CSF2 and Sepsis: Recombinant GM-CSF can reverse monocyte deactivation in sepsis and rescues patients from sepsis-associated immunosuppression [51] and rGM-CSF administration facilitates alveolar macrophage-dependent protection in mice infected with influenza virus [52].